Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 7, 2014, Pages 737-743

  Pacifico, L ^a   Bonci, E ^b   Andreoli, G ^a   Romaggioli, S ^a   Di Miscio, R ^a   Lombardo, C V ^a   Chiesa, C ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Carotid artery intima media thickness; Children; Insulin resistance; Nonalcoholic fatty liver disease; Triglyceride to HDL cholesterol ratio

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERY; CROSS-SECTIONAL STUDY; FOLLOW UP; LIVER; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADOLESCENT; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LIVER; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OVERWEIGHT; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84901917294     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.01.010     Document Type: Article

References (31)

1. Haslam D.W., James W.P. Obesity. Lancet 2005, 366:1197-1209.
2. Millán J., Pintó X., Muñoz A., Zúñiga M., Rubiés-Prat J., Pallardo L.F., et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009, 5:757-765.
3. Kannel W.B., Vasan R.S., Keyes M.J., Sullivan L.M., Robins S.J. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol 2008, 101:497-501.
4. Salazar M.R., Carbajal H.A., Espeche W.G., Leiva Sisnieguez C.E., Balbín E., Dulbecco C.A., et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 2012, 109:1749-1753.
5. Quijada Z., Paoli M., Zerpa Y., Camacho N., Cichetti R., Villarroel V., et al. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes 2008, 9:464-471.
6. Musso C., Graffigna M., Soutelo J., Honfi M., Ledesma L., Miksztowicz V., et al. Cardiometabolic risk factors as apolipoprotein B, triglyceride/HDL-cholesterol ratio and C-reactive protein, in adolescents with and without obesity: cross-sectional study inmiddle class suburban children. Pediatr Diabetes 2011, 12:229-234.
7. Weiss R., Otvos J.D., Sinnreich R., Miserez A.R., Kark J.D. The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr 2011, 158:44-50.
8. Giannini C., Santoro N., Caprio S., Kim G., Lartaud D., Shaw M., et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 2011, 34:1869-1874.
9. Di Bonito P., Moio N., Scilla C., Cavuto L., Sibilio G., Sanguigno E., et al. Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care 2012, 35:158-162.
10. Urbina E.M., Khoury P.R., McCoy C.E., Dolan L.M., Daniels S.R., Kimball T.R. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics 2013, 131:e1082-e1090.
11. de Giorgis T., Marcovecchio L., Di Giovanni I., Giannini C., Chiavaroli V., Chiarelli F., et al. Triglycerides to high density lipoprotein ratio as a new marker of endothelial dysfunction in obese prepubertal children. Eur J Endocrinol 2013, 170:173-180.
12. Raitakari O.T., Juonala M., Kähönen M., Taittonen L., Laitinen T., Mäki-Torkko N., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277-2283.
13. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
14. Pacifico L., Cantisani V., Ricci P., Osborn J.F., Schiavo E., Anania C., et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008, 63:423-427.
15. Cole T.J., Bellizzi M.C., Flegal K.M., Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320:1240-1243.
16. Schwimmer J.B., Dunn W., Norman G.J., Pardee P.E., Middleton M.S., Kerkar N., et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010, 138:1357-1364.
17. Cook S., Auinger P., Huang T.T. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr 2009, 155(Suppl. 6):e15-e26.
18. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(Suppl. 2):555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
19. Pacifico L., Anania C., Martino F., Cantisani V., Pascone R., Marcantonio A., et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52:1643-1651.
20. Maki K.C., Davidson M.H., Dicklin M.R., Bell M., Witchger M., Feinstein S.B. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease. J Clin Lipidol 2011, 5:141-151.
21. Nicholls S.J., Tuzcu E.M., Wolski K., Bayturan O., Lavoie A., Uno K., et al. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study. J Am Coll Cardiol 2011, 57:153-159.
22. Shimizu Y., Nakazato M., Sekita T., Kadota K., Yamasaki H., Takamura N., et al. Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: the Nagasaki Islands Study. Atherosclerosis 2013, 228:491-495.
23. Koba S., Hirano T., Ito Y., Tsunoda F., Yokota Y., Ban Y., et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 2006, 189:206-214.
24. deGoma E.M., Leeper N.J., Heidenreich P.A. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol 2008, 51:49-55.
25. Barter P., Gotto A.M., LaRosa J.C., Maroni J., Szarek M., Grundy S.M., et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007, 357:1301-1310.
26. McLaughlin T., Reaven G., Abbasi F., Lamendola C., Saad M., Waters D., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 2005, 96:399-404.
27. Cordero A., Laclaustra M., León M., Casasnovas J.A., Grima A., Luengo E., et al. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol 2008, 102:424-428.
28. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
29. Pacifico L., Nobili V., Anania C., Verdecchia P., Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011, 17:3082-3091.
30. Steinberger J., Daniels S.R., Eckel R.H., Hayman L., Robert H., Lustig R.H., et al. Progress and challenges in metabolic syndrome in children and adolescents. A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009, 119:628-647.
31. Pacifico L., Arca M., Anania C., Cantisani V., Di Martino M., Chiesa C. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013, 23:1010-1016.